openPR Logo
Press release

Multiple Myeloma Drugs Market Analysis 2023: Market Statistics, Segments, Size, Trends And Forecast To 2032 | Pfizer Inc., Johnson & Johnson Pvt. Ltd, Merck & Co. Inc., AbbVie Inc., Bayer AG

09-22-2023 07:33 AM CET | Health & Medicine

Press release from: The Business research company

Multiple Myeloma Drugs Market

Multiple Myeloma Drugs Market

The Business Research Company's global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

The Business Research Company's Multiple Myeloma Drugs Global Market Report 2023 identifies increasing prevalence of hematological cancer as the major driver for the Multiple Myeloma Drugs market's growth in the forecast period. Hematological cancers start in blood-forming tissue, such as bone marrow, or immune system cells, such as leukemia, lymphoma, multiple myeloma, and others. 

The global multiple myeloma drugs market size is expected to grow from $19.37 billion in 2022 to $20.7 billion in 2023 at a compound annual growth rate (CAGR) of 6.8%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The size of multiple myeloma drugs market is expected to reach $26.3 billion in 2027 at a CAGR of 6.2%.

Download Free Sample Of Multiple Myeloma Drugs Market Report - https://www.thebusinessresearchcompany.com/sample.aspx?id=11943&type=smp

Major competitors in the Multiple Myeloma Drugs market are Pfizer Inc., Johnson & Johnson Pvt. Ltd, Merck & Co. Inc., AbbVie Inc., Bayer AG.

A key trend in the Multiple Myeloma Drugs market includes Product innovation. Major companies operating in the multiple myeloma drugs market are focused on developing innovative products to strengthen their position and gain a competitive advantage. For instance, in March 2022, Janssen Biotech Inc., a Japan-based biotechnology company, received the United States Food and Drug Administration approval for Carvykti, a CAR T-Cell therapy (personalized immunotherapy) for multiple myeloma. CARVYKTI (ciltacabtagene autoleucel) is a genetically modified autologous cell-based product composed of T cells transduced ex vivo with a replication-incompetent lentiviral vector encoding an anti-B cell maturation antigen (BCMA) chimeric antigen receptor (CAR) consisting of two single domain antibodies linked to a 4-1BB costimulatory domain and a CD3-zeta signaling domain. Patients who have received four or more lines of therapy, including treatment with three critical kinds of multiple myeloma medications (an immunomodulating agent, a proteasome inhibitor, and an anti-CD38 monoclonal antibody), are eligible to receive it to treat relapsed conditions.

Read More On The Global Multiple Myeloma Drugs Market Report Here:
https://www.thebusinessresearchcompany.com/report/multiple-myeloma-drugs-global-market-report

The Multiple Myeloma Drugs market is segmented -

1. By Drug Type: Immunomodulatory Drugs, Proteasome Inhibitors, Histone Deacetylase Inhibitors, Monoclonal Antibody Drugs, Steroids, Other Drug Types
2. By Therapy: Targeted Therapy, Biologic Therapy, Chemotherapy, Other Therapies
3. By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Other Distribution Channels
4. By End-User: Men, Women
5. By Geography: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. North America was the largest region in the Multiple Myeloma Drugs market.

The Business Research Company's "Global Multiple Myeloma Drugs Market Report 2023" provides a thorough understanding of the market across 60 geographies. The report covers market size, growth rate, segments, drivers and trends in every region and country. In addition, the report offers insights on historical and forecast growth, helping players analyze and strategize better.

Explore Buying Options For The Multiple Myeloma Drugs Market Report Here:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=11943

The Table Of Content For The Multiple Myeloma Drugs Market Include:

1. Executive Summary
2. Multiple Myeloma Drugs Market Characteristics
3. Multiple Myeloma Drugs Market Trends And Strategies
4. Multiple Myeloma Drugs Market - Macro Economic Scenario
……
32. Global Multiple Myeloma Drugs Market Competitive Benchmarking
33. Global Multiple Myeloma Drugs Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Multiple Myeloma Drugs Market
35. Multiple Myeloma Drugs Market Future Outlook and Potential Analysis
36. Appendix

Contact us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Latest Trending Press Releases: https://www.thebusinessresearchcompany.com/press-release.aspx

Want To Know More About The Business Research Company?
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialise in various industries including manufacturing, healthcare, financial services, chemicals, and technology.

Global Market Model - World's Most Comprehensive Database
The Business Research Company's flagship product, Global Market Model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Multiple Myeloma Drugs Market Analysis 2023: Market Statistics, Segments, Size, Trends And Forecast To 2032 | Pfizer Inc., Johnson & Johnson Pvt. Ltd, Merck & Co. Inc., AbbVie Inc., Bayer AG here

News-ID: 3218135 • Views:

More Releases from The Business research company

Truck Scale Market Poised for Robust Growth, Projected to Hit $3.43 Billion by 2 …
How Much Is the Truck Scale Market Expected to Expand by 2025? The truck scale market has experienced robust expansion lately, projected to ascend from its 2024 valuation of $2.48 billion to attain $2.66 billion by 2025, reflecting a compound annual growth rate (CAGR) of 7.0%. This past growth trajectory has been fueled by several key factors, notably the escalating requirement for precise gross vehicle weight determinations, the wider integration of
Surging Application Across End Users Powers the Expansion of the Thermosetting A …
What Is the Projected Size of the Thermosetting Acrylic Adhesive Market by 2025? The market for thermosetting acrylic adhesives has experienced robust expansion recently, projecting an increase from $1.16 billion in 2024 to $1.24 billion in 2025, reflecting a compound annual growth rate of 6.7%; this upswing during the past period stems from heightened requirements within the automotive sector, greater incorporation in building projects, escalating uptake in the creation of electronic
Consistent Growth Projected for Temporary Floor Protection Market, Reaching $2 B …
How Much Is the Temporary Floor Protection Market Expected to Expand by 2025? The temporary floor protection sector has experienced robust expansion lately, projected to elevate its market valuation from 1.41 billion USD in 2024 to 1.52 billion USD by 2025, reflecting a compound annual growth rate of 7.6 percent; this earlier period's upward trend stems from a surge in building undertakings, an upward trend in refurbishment assignments, escalating requirements within
Accelerated Digital Transformation Fuels Expansion in the Talent Marketplace For …
What Is the Projected Size of the Talent Marketplace For Creators Market by 2025? The sphere of the creator talent marketplace is characterized by swift expansion recently, projected to climb from a valuation of $9.65 billion in 2024 to $11.47 billion in 2025, reflecting a compound annual growth rate (CAGR) of 18.9%; this past growth trajectory has been fueled by several factors, including escalated needs for digital media output, a broadening

All 5 Releases


More Releases for Drug

Injectable Drug Delivery Market Injectable Drug Delivery Market
Leading market research firm SkyQuest Technology Group recently released a study titled ' Injectable Drug Delivery Market Global Size, Share, Growth, Industry Trends, Opportunity and Forecast 2024-2031,' This study Injectable Drug Delivery report offers a thorough analysis of the market, as well as competitor and geographical analysis and a focus on the most recent technological developments. The research study on the Injectable Drug Delivery Market extensively demonstrates existing and upcoming
Global Advanced Drug Delivery Systems Market Size - By Product Type(Oral Drug De …
Market Overview and Report Coverage Advanced Drug Delivery Systems (ADDS) refer to innovative technologies designed to improve the administration and efficacy of therapeutics, enhancing the way medications are delivered to targeted areas within the body. These systems aim to optimize treatment outcomes by increasing the bioavailability, reducing side effects, and facilitating controlled drug release. Employing methods such as nanoparticles, liposomes, and implantable pumps, ADDS are revolutionizing personalized medicine and expanding therapeutic
Global Cancer Antibody Drug Conjugate Market Size, Drug Sales, Drug Dosage, Pric …
Global Cancer Antibody Drug Conjugate Market Size, Drug Sales, Drug Dosage, Price, and Clinical Trials Outlook 2029 Report Highlights: * Global Antibody Drug Conjugates Market Opportunity: > 40 Billion By 2029 * Global and Regional Antibody Drug Conjugate Market Insight * Approved Drugs Sales Insight Global and Regional, Yearly and Quarterly, 2019 -2023 * Approved Antibody Drug Conjugates - Availability, Dosage and Price Insight * Insight On Antibody Drug Conjugates In Clinical Trials: > 550
Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions. Alcohol abuse and drug
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.  Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Introduction to Hepatitis Disease 1.1 Prologue 1.1.1 History of Hepatitis 1.1.2 Causes of Hepatitis Disease 1.2 Types of Viruses which are Responsible for Hepatitis Disease 2. Global Prevalence of Hepatitis Infection 3. Available Drug Classes for Hepatitis Disease Treatment 3.1 Interferon Alfa Therapy 3.2 Protease Inhibitors Therapy 3.3 Polymerase